Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes by Wen, Haitao et al.
Dendritic cells at the interface of innate and acquired
immunity: the role for epigenetic changes
Haitao Wen,* Matthew A. Schaller,* Yali Dou,*,† Cory M. Hogaboam,* and Steven L. Kunkel*,1
Departments of *Pathology and †Biological Chemistry, University of Michigan Medical School, Ann Arbor,
Michigan, USA
Abstract: Dendritic cells (DC) are known to be
essential immune cells in innate immunity and in
the initiation of adaptive immunity. The shaping of
adaptive immunity by innate immunity is depen-
dent on DC unique cellular functions and DC-de-
rived effector molecules such as cytokines and che-
mokines. Thus, it is not surprising that numerous
studies have identified alterations in DC number,
function, and subset ratios in various diseases, such
as infections, cancers, and autoimmune diseases.
Recent evidence has also identified that immuno-
suppression occurring after severe systemic in-
flammation, such as found in sepsis, is a result of
depletion in DC numbers and a later dysfunction in
DC activity. This correlation suggests that the sus-
tained DC dysfunction initiated by life-threatening
inflammation may contribute to the subsequent im-
munoparalysis, potentially as a result of the long-
term maintenance of an abnormal gene expression
pattern. In this review, we summarized the present
information regarding altered DC function after a
severe, acute inflammatory response and propose a
mechanism, whereby epigenetic changes can influ-
ence long-term gene expression patterns by DC,
thus supporting an immunosuppression phenotype.
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INTRODUCTION
Since the first description by Steinman’s group as a novel cell
population in the mouse spleen [1–3], dendritic cells (DC) have
been recognized as a key component to innate immunity and in
the initiation of an adaptive immune response [4]. DC are
relatively rare cells and are mainly localized in tissues exposed
to external environments, such as the respiratory system and
gastrointestinal tract, where they reside in an immature form
and serve as sentinels. Immature DC express a number of
pathogen recognition receptors (PRRs), including TLRs, c-type
lectin receptors, and nucleotide-binding oligomerization do-
main-like receptors, which aim to detect pathogen-associated
molecule patterns. DC also participate in cell-mediated immu-
nity by taking up antigen and incompletely degrade them into
peptides optimal for presentation by relevant MHC and CD1
molecules [5]. The activation of DC by pathogen-derived mol-
ecules induces a switch in chemokine receptor expression and
subsequent migration to draining lymph nodes in a chemokine
receptor-dependent manner. The up-regulation of costimula-
tory (CD80, CD86, CD40) and MHC molecules, in conjunction
with secretion of cytokine and chemokines, facilitates DC
antigen presentation to naı̈ve T cells with an antigen-specific
receptor [6].
Given their essential role in the immune response, any
alteration in DC number and/or function would impair normal
immune activity and subsequently render the host susceptibil-
ity to secondary pathological challenges. Interestingly, a num-
ber of clinically important diseases have been identified that
target the DC and reduce their ability to fully function in host
defense. For example, infection of DC with measles suppresses
their allostimulatory properties for CD4 T cells [7]. Systemic
activation of DC by TLR agonists or infection with a malaria
parasite (Plasmodium berghei) impairs their cross-presentation
and antiviral functions [8]. Tumors may secrete regulatory
cytokines such as IL-10, TGF-, and vascular endothelial
growth factor and reduce DC development and function, re-
sulting in attenuated expression levels of CD80 and CD86 on
tumor-infiltrating DC [9]. Furthermore, tumors can convert
immature DC into TGF--secreting cells, which subsequently
induce the proliferation of regulatory T cells [10] and enhance
the production of Th2 cytokines (IL-4 and IL-13) by naı̈ve
CD4 T cells [11].
One of the best examples of DC dysfunction associated with
a disease state is presented by studies investigating the mo-
lecular and cellular mechanisms of severe sepsis in patients
and experimental models. It is clear that patients who survive
severe sepsis are more susceptible to a variety of diseases long
after being discharged from the intensive care unit [12, 13]. In
an experimental study of severe sepsis, cecal ligation and
puncture (CLP) has been proposed to replicate the nature and
course of polymicrobial-induced clinical sepsis [14, 15]. The
benefits of the CLP model are its reproducibility and the
potential to alter the severity of sepsis by controlling needle
size, number of cecal punctures, and antibiotics use [16]. Our
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CLP procedure results in 40% mortality in the acute phase of
sepsis [17–19]. Following the induction of CLP-induced peri-
tonitis, inflammatory cytokines/chemokines such as IL-12p70,
IL-10, TNF-, CCL2, CCL3, and CXCL10 are rapidly induced
in the peritoneal cavity (local response; Fig. 1A) and blood
(Fig. 1B) within 4 h and peak at 24 h. Three days later, the
local and systemic levels of inflammatory cytokines/chemo-
kines mostly return to baseline levels, indicating the end of the
acute phase of sepsis. It has been demonstrated that animals
surviving septic peritonitis induced by CLP were more suscep-
tible to a secondary fungal challenge [17]. Thus, clinical re-
ports and experimental animal studies conclude that an enig-
matic complication of severe sepsis is a lasting, immunosup-
pressive state. While the molecular and cellular mechanisms
that support this immunoregulation remain elusive, it is known
that rapid DC depletion as a result of extensive apoptosis
following the acute phase of severe sepsis is a contributing
factor [20]. Impairment in DC functions, including cytokine
production and allogeneic T cell activation, has also been
reported, although the underlying, molecular mechanism for
these altered responses is not clear [18, 21].
Recent data support the concept that specific gene expres-
sion patterns, which determine the behavior and property of
individual cells, are under the control of epigenetic alterations.
These effects are exerted via a variety of chemical modifica-
tions to chromatin structure, including DNA methylation, his-
tone modification, chromatin remodeling, and histone replace-
ment, and have been studied extensively in normal embryo-
genesis and cancer [22–24]. Although the exact molecular
mechanism(s) is still under intensive investigation [25, 26], it
is accepted that epigenetic alterations can be transmitted from
generation to generation and carry heritable information that is
not coded by genomic DNA. The long-term alteration in DC
functions, which correlates with sustained immunosuppression
following severe sepsis, supports the concept for a potential
epigenetic-dependent mechanism in this process.
DC IN SEPTIC RESPONSE
There is little doubt that DC, although small in number, play a
large role in maintaining an appropriate and protective innate
and acquired host response. Therefore, DC are logical partic-
ipants in the initial severe infection and dysregulated cytokine
storm in the early stage of severe sepsis. Indeed, DC undergo
a rapid depletion in septic patients [27] and in experimental
sepsis animal models [21, 28–31]. Thus, severe sepsis causes
the depletion of DC, a potent APC, which subsequently com-
promises the innate and adaptive immune response [20]. A
kinetic analysis of DC subtypes following the induction of
experimental peritonitis identified a depletion of myeloid DC
and plasmacytoid DC (pDC) in secondary lymphoid organs
(spleen and lymph node) and peripheral organ (lung). Interest-
ingly, the DC populations are reseeded to the distant organs, as
their numbers gradually return to normal levels after a signif-
icant recovery period (H. Wen and S. L. Kunkel, unpublished
data). It remains unclear where the generation of DC subtypes
from their precursor occurs post-sepsis. It is possible that DC
are newly generated in bone marrow and migrate to peripheral
sites via the action of chemokines [32]. Another possibility is
that DC are generated in peripheral sites from precursor cells,
which have been recruited into the periphery during the severe
inflammatory response. It is important to answer these ques-
tions, as normal hematopoiesis is influenced by the surround-
ing tissue microenvironment (hematopoietic niche) [33, 34].
The tissue location in which DC are generated will definitely
contribute to the final DC phenotypes and direct the properties
of newly generated DC.
Based on the long-term susceptibility of septic patients to
secondary pathological infections [35] and our observation of a
gradual restoration of DC number after severe sepsis, it is
highly possible that sepsis-induced depletion of immune cells
is not the only mechanism responsible for the long-term im-
munosuppression present in post-septic patients and animals.
Alterations of normal immune cell functions could be another
potential mechanism leading to an inappropriate immune re-
sponse. It is worth noting that apoptosis and dysfunction of
immune cells are not exclusive to each other. It has been
reported that apoptotic cells induce anergy and a Th2 response
in surviving immune cells [20, 36, 37], promote the production
of anti-inflammatory cytokines by DC and macrophage [38],
and inhibit the release of proinflammatory cytokines [39, 40].
In contrast to the convincing data showing sepsis-induced
Fig. 1. Cytokine profile following experimental peritonitis. At different time-points (4, 24, and 72 h) after the CLP procedure, peritoneal lavage fluid (A) and blood
samples (B) were collected. Levels of inflammatory cytokines were determined by ELISA.
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depletion of immune cells, few investigations have focused on
alteration in immune cell function after sepsis. Previously, our
group has characterized the immunosuppressive status of the
survivors of severe experimental sepsis. These post-septic mice
were susceptible to a pulmonary challenge of Aspergillus fu-
migatus compared with sham-operated mice, highlighting im-
paired pulmonary immunity in post-septic mice. A. fumigatus
was chosen as the microbial challenge, as this fungus normally
is not a pathogen for an intact pulmonary immune system [17,
41]. Furthermore, adoptive transfer of bone marrow-derived DC
from sham mice restored the protective immune response of
post-septic mice to A. fumigatus challenge. These observations
led us to hypothesize that severe sepsis-induced DC dysfunc-
tion is an important mechanism of long-term immunosuppres-
sion after the acute phase of sepsis.
CHRONIC CONSEQUENCES OF SEVERE
SEPSIS
General consensus supports the idea that the acute inflamma-
tory response is intimately linked to innate immunity, which
usually occurs over a relatively short period. During this lim-
ited time-frame, a functional, acute inflammatory response is
supported by the temporal expression of a set of inflammatory
mediators and activation of specific leukocyte subpopulations.
For example, within the first hour of in vivo LPS challenge,
mRNA expression for early response cytokines such as TNF-
can be detected in mononuclear phagocytic cells, followed by
the expression of secondary response cytokines and chemo-
kines [42, 43]. In animal experiments, this acute cytokine
phase is followed by the recruitment of neutrophils, which
occurs within hours [44]. Over the subsequent 72 h, cytokine,
chemokine, and leukocyte levels will usually subside, and any
alteration in local tissue will begin to be repaired [44].
Interestingly, this scenario is dependent on the quantity and
complexity of the initial antigen or pathogen [44, 45]. An
increase in the amount of stimuli will result in an enhanced
cytokine and leukocyte response, and an increase in the com-
plexity of the challenge may lead to a prolonged reaction. An
additional factor that determines the clinical course of an acute
inflammatory response is the rigor of the host’s immune re-
sponse to the inciting agent [35, 46]. This aspect of the re-
sponse has important consequences for the short-term course of
the acute reaction and also appears to play a key role regarding
the host’s response to a subsequent challenge that occurs long
after the initial severe acute reaction. An interesting inverse
clinical correlation exists between the severity of the initial
acute inflammatory response and the ability of the host to deal
with a subsequent immune challenge months later [35, 47, 48].
As noted above, one of the best examples of the chronic
effects of severe acute inflammation is presented by data
modeled from human sepsis. A variety of investigations has
studied the short-term, less-than-30-days sequela of the septic
response and has reported mortalities that approach 50% [13].
Additional investigations have noted that the septic population
is at a significant risk of dying for many years after the initial
hospitalization [35]. Septic patients develop a sustained anti-
inflammatory or immunosuppressive state that has been termed
“immunoparalysis” following the initial hyperinflammatory re-
sponse, which is manifested by an inability to eradicate the
primary infection and/or the development of new secondary
infections [12, 13, 41, 49–51]. Many of the pathogens respon-
sible for the secondary, hospital-acquired infections are not
particularly pathological in patients with competent immune
systems, indicating the immunosuppressive state of patients
with sepsis. Thus, the initial episode of severe sepsis, charac-
terized by a dysregulated, inflammatory response, leads to
long-lasting complications regarding how the host responds to
and deals with subsequent challenges. The chronic conse-
quences linked to severe acute inflammation are not limited to
sepsis but are found in other severe acute human diseases,
including the long-term consequences of acute ischemia/reper-
fusion injury post-organ transplant [52], post-recovery alter-
ations from severe respiratory syncial viral infection in neo-
nates [53, 54], and the chronic consequences observed in
response to severe burn and trauma injury [55, 56]. Many of
these clinical cases appear to be governed by severe, life-
threatening, inflammatory events, followed by a long-lasting,
improper or immunosuppressed immune response.
EPIGENETIC MECHANISM OF GENE
REGULATION
Epigenetics is the study of mitotically and/or meiotically her-
itable changes in gene function that cannot be explained by
changes in DNA sequence. These changes include DNA meth-
ylation, histone modification, chromatin remodeling, and his-
tone variant incorporation [57]. In the last decade, biologists
have convincingly demonstrated that the regulation of chroma-
tin structure or epigenetic regulation confers heritable stabili-
zation of gene expression patterns and thereby, plays an es-
sential role in basic physiological processes and in diseases
[22, 58]. In addition to interactions between transcription
factors and DNA sequences in promoters and other regulatory
regions, gene expression is influenced by epigenetic changes in
chromatin structure that control the access of DNA-binding
proteins to their conserved sites during the initiation period of
transcription. Conversely, transcription factors can dictate epi-
genetic changes by recruiting histone-modifying enzymes and
chromatin-remodeling complexes.
In eukaryotic cells, DNA is packed into a high-order nuclear
structure, called chromatin, with the assistance of chromo-
somal proteins, including histones (Fig. 2). The basic unit of
chromatin is the nucleosome, which consists of 146 bp of
double-strand DNA wrapped around a histone octamer protein
core (two molecules each of H2A, H2B, H3, and H4) [59, 60].
At present, histone modifications, including acetylation, phos-
phorylation, methylation, and ubiquitylation, are under inten-
sive investigation and have been considered to be important
epigenetic mechanisms regulating gene expression. These
modifications, catalyzed by several families of histone-modify-
ing enzymes, form a “histone code” that constitutes an impor-
tant epigenetic determinant of the transcriptional state [25, 61].
Individual histone modifications can be simply categorized as
“permissive” or “repressive”, in reference to gene transcrip-
tional activity. For example, histone acetylation is generally
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associated with gene activation, partially as a result of neutral-
ization of the positive charge on lysine and a consequent
lowered stability of interactions between histones and the
negatively charged DNA [62].
In addition, histone methylation is recognized as an im-
portant modification linked to transcriptional activation and
repression [61]. As the first observation of histone methyl-
ation was to regulate RNA synthesis, Jenuwein’s group in
2000 [63] made a landmark discovery of molecular identity
of the first histone methyltransferase (HMT), SUV39H1.
Histones contain numerous lysine and arginine residues and
can be modified on both residues with up to three methyl
groups. Methylation of lysine residues at six sites (H3K4, -9,
-27, -36, and -79 and H4K20) has been linked to transcrip-
tional regulation [61, 64], which in conjunction with various
methylation levels (mono-, di-, or trimethylation), provides
remarkable regulatory potentials for chromatin modification
and gene regulation.
Lysine methylation is mediated by the Su(var)3-9, Enhancer
of Zeste, Trithorax (SET) domain, which was initially charac-
terized as a common motif in three main classes of HMTs in
Drosophila: SU(VAR)3-9 [65], the Polycomb-group protein
E(Z) [66], and trithorax protein [67]. They are specifically
responsible for the methylation of H3K9, H3K27, and H3K4,
respectively. H3K4 methylation (H3K4me) generally corre-
lates with gene activation and is therefore considered a per-
missive modification. H3K4me3 has been found to be associ-
ated with the promoter and 5-coding regions of active genes in
yeast and higher eukaryotes, indicating the specific function of
H3K4me3 in the initiation of gene transcription [61, 68]. MLL,
a mammalian homologue to the Drosophila trithorax protein, is
one of the best-characterized members of the H3K4 HMT
family [69] and was isolated as a common target of chromo-
somal translocations observed in human acute leukemia [70].
MLL forms a HMT complex, in conjunction with other core
components, including WD40-repeat protein WDR5, RbBP5,
and Ash2L [71, 72] (Fig. 2). A deficiency of each of these
subunits impairs MLL methyltransferase enzyme activity [71,
72]. H3K27 trimethylation and H3K9 di- and trimethylation
contribute to the maintenance of repressive chromatin struc-
ture and correlate with gene silencing [64, 73, 74]. Methyl
H3K9 serves as a binding site for the chromodomain-contain-
ing protein heterochromatin protein HP1, which is essential for
the establishment and maintenance of silent chromatin (het-
erochromatin) [75, 76]. Methyl H3K27 offers a binding site for
a chromodomain-containing protein Polycomb, a core compo-
nent of PRC1, which together with PRC2 (also known as
EED-EZH2 complex), has a pivotal role in silencing the de-
velopmentally important Hox gene and X-chromosome inacti-
vation [64]. PRC2 possesses several core components, EZH2,
SUZ12, and EED. EZH2 has a SET domain and possesses an
intrinsic HMT enzyme activity, and methylation of H3K27 by
EZH2 subsequently recruits PRC1, which exhibits a ubiquitin
E3 ligase activity and influences gene transcription via the
ubiquitylation of histone H2A [64].
Fig. 2. Diagram of the biochemical effects of methylation at histone H3 lysine-27 (H3K27), which maintains the chromatin in a conformation that does not allow
transcription factors access to a promoter, and the gene is silenced. When H3K4 is methylated, the conformation of the chromatin is relaxed, and the transcription
factors now have access to the promoter, resulting in gene expression. Mixed lineage leukemia (MLL) complex, containing core components MLL, WDR5, RbBP5,
and Ash2L, possesses methyltransferase enzyme activity specific for H3K4, while Polycomb repressive complex 2 (PRC2), containing embryonic ectoderm
development (EED), enhancer of Zeste 2 (EZH2), and suppressor of Zeste 12 (SUZ12), specifically mediates H3K27 methylation.
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EPIGENETIC REGULATION OF GENES IN
IMMUNE SYSTEM
A lingering conundrum of the immune response is how do
certain immune/inflammatory cells “remember” whether they
should be actively transcribing specific genes, which would
facilitate their participation in a given response. Considering
the property of inheritance and stability, the epigenetic mech-
anisms may be involved in the maintenance of cell memory. It
has been documented convincingly that the maintenance of
memory Th1 and Th2 cells depends on chromatin modifica-
tions, including histone acetylation, methylation, and DNA
methylation. The Th2 locus containing Il5, Rad50, Il13, and
Il4 genes has been well-characterized to exhibit distinct com-
binations of individual chromatin modifications that correlate
with different gene expression patterns [77]. There are three
stages during the development of Th1/Th2 cells, including the
initiation of Th2 differentiation, reinforcement of Th2 pheno-
type, and maintenance of Th2 fate. Multiple key transcription
factors and signaling pathways have been revealed to be es-
sential for the first two stages, such as IL-4/IL-4R/STAT6
pathway, NFAT, and GATA3 [78, 79]. Deficiency of these
molecules inhibits normal Th2 development in vitro and in vivo
[77–79]. However, GATA3, a Th2-specific transcription fac-
tors, is not absolutely required for IL-4 production during the
maintenance stage of Th2 cells, as conditional depletion of
GATA3 in differentiated Th2 cells only results in a minor
decrease in IL-4 production without affecting the total number
of cells capable of producing IL-4 [80]. This observation
strongly suggests that differentiated Th2 cells have acquired
“cellular memory” of Th2 cytokine production without the
further requirement of polarizing signals, which are essential
for the initial establishment of this memory. Indeed, subse-
quent studies of chromatin modifications in Th2 locus during
Th1/Th2 development have revealed that Th2 memory was
conferred by permissive histone modifications, while repres-
sive modifications were associated with silencing of Th2 locus
in differentiated Th1 cells [77]. These data clearly show that
the long-term maintenance of Th1/Th2 or “Th1/Th2 memory”
correlates with distinct histone modifications.
In addition to the Th1/Th2 paradigm, the newly discovered
effector T cell lineage, Th17, has been linked to epigenetic
changes in Il17 locus [81]. Compared with Th1 or Th2 cells,
Th17 cells exhibited an enhanced histone acetylation and
H3K4me3 at Il17 promoter region, which is consistent with the
general concept discussed above.
Recent study of LPS tolerance has expanded the under-
standing of epigenetic regulation and maintenance of gene
expression in immune system to macrophages [82]. Restimu-
lation of macrophage with LPS results in an attenuated inflam-
matory response (LPS-tolerance) but maintains an intact anti-
microbial response, which is represented by two kinds of
genes—tolerizeable and nontolerizeable, respectively. Toler-
izeable genes lose the permissive histone modifications—
H4Ac and H3K4me3—at their promoter regions during a
secondary challenge with LPS, whereas nontolerizeable genes
still are able to mount the permissive histone modifications—
H4Ac and H3K4me3—in response to a secondary LPS chal-
lenge, which correlates with intact capacity in gene transcrip-
tion. Thus, short-term cellular memory of tolerized macro-
phages is at least in part a result of the regulation of the gene
expression pattern by epigenetic changes at gene-specific loci
[83]. This study suggests that analogs to adaptive immune
cells, the cells of the innate immune system, are also capable
of mounting cell memory in response to specific external stim-
uli. Regarding the essential roles of innate immune response in
pathological conditions, including infections, cancer, and au-
toimmune diseases, the epigenetic mechanism-mediated in-
nate immune cell memory has significant clinical relevance.
Epigenetic memory in innate immune cells may potentially
explain long-term maintenance of some disease conditions,
presumably through the effects of aberrant cell phenotype and
gene expression patterns, such as immunoparalysis induced by
severe sepsis or macrophage polarization (M1/M2) in tumor-
genesis [84]. Further investigations are required to character-
ize molecular mechanism(s) responsible for epigenetic changes
and the establishment of cell memory.
A number of laboratories have identified that severe, life-
threatening experimental sepsis initially induces a rapid cyto-
kine storm followed by a profound depletion of immune cells in
the lung, spleen, and bone marrow [20, 21, 28–31, 85]. As
stated above, this is especially apparent in the depletion of DC
in these tissues. In the animals that become long-term survi-
vors, DC are repopulated; however, they appear to possess an
impaired ability to function in normal innate and acquired
immune events. Our previous work has identified that an
important cytokine needed to promote and maintain immune
responsiveness, IL-12, was chronically altered in CLP-induced
experimental severe sepsis [18, 19]. Our data indicate that
splenic DC showed a significant impairment in IL-12 produc-
tion, an essential cytokine directing Th1 immune response
[86], at least 6 weeks after CLP. To test if the epigenetic
alterations such as histone modifications play a role in the
maintenance of impaired IL-12 expression in DC isolated from
septic mice, we performed chromatin immunoprecipitation as-
say, a classical technique to study histone modifications and
the binding of transcription factors on promoter regions. We
have observed H3K4me3 and H3K27me2 at the promoter
regions of Il12 subunits, Il12p35 and Il12p40, in normal
splenic DC. A decreased ratio between H3K4me3 and
H3K27me2 at Il12 promoters was observed in post-septic
splenic DC, which correlated with down-regulation of Il12 gene
expression. Furthermore, the decreased ratio of H3K4me3 and
H3K27me2 was a result of altered binding of cognate HMT
complexes. For example, post-septic splenic DC possessed
decreased binding of core components of the MLL complex,
WDR5 and RbBP5, but enhanced binding of core components
of the PRC2 complex, EED and SUZ12. Thus, the involvement
of histone modifications in the maintenance of an altered Il12
expression pattern in DC long-term following severe sepsis has
been indicated.
CONCLUDING REMARKS
Based on the property of inheritance, stability, and its role in
immune system, we propose that the long-term maintenance of
DC alterations may be a result of epigenetic regulation of
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expression patterns of key effector molecules. Figure 3 out-
lines an evolving hypothesis of the cellular and molecular
mechanism by which an initial, overwhelming innate immune
response leads to a long-term immunosuppressive state such
that the affected host loses the immune capacity to mount an
appropriate defense response against a secondary pathological
challenge. The key part of this hypothesis includes long-term,
abnormal DC differentiation from precursor cells and the main-
tenance of DC dysfunction mediated by an epigenetic mecha-
nism, which can profoundly control the transcription of specific
genes. Then, an important question follows: What are the key
molecules/signals mediating epigenetic alterations in DC post-
epsis? The informative data came from experiments studying
LPS-stimulated macrophages [82]. LPS-TLR4 signaling in-
duces a short-term LPS unresponsiveness of macrophages,
which is mediated by alterations in histone modifications. This
study indicates that TLR signaling is a potential contributor of
epigenetic changes; however, signaling through TLR4 alone is
not sufficient to build a long-term immune cell memory. In
memory T cells, the candidate pathways leading to epigenetic
alterations include TCR and cytokine/cytokine receptor signal-
ing pathways. Based on the fact that overwhelmed pathological
infection and dysregulated cytokine storm are hallmarks of
severe sepsis, it is reasonable to hypothesize that TLR signal-
ing and cytokine/cytokine receptor signaling pathways are
potential contributors to the epigenetic changes. In addition, it
is highly possible that the synergy between individual TLR
signaling exists, resulting in the eventual downstream epige-
netic changes, as synergy between different TLR signaling has
been shown to promote Th1-polarizing function of DC [87].
Our recent data suggest that long-term alterations, which
modify the balance of crucial cell-derived mediators and dis-
rupt the normal functions of these cells, are directed by
changes in DC phenotype and alterations in the expression of
important host defense genes. Some of these changes are
correlated with covalent modification of histone proteins, which
can profoundly control the transcription of specific genes. More
evidence of the role of the epigenetic alterations in long-term
DC dysfunction following acute inflammatory response and
further investigation of upstream signaling pathways leading to
these epigenetic changes will provide mechanistic insight into
the longer-term sequela of sepsis and begin to lay the ground-
work for the development of potentially novel cell and media-
tor-based therapeutic interventions.
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